Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Intervalo de año de publicación
1.
Chem Biodivers ; : e202402100, 2024 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-39327235

RESUMEN

Microorganisms can induce diseases with significant clinical implications for human health. Multidrug-resistant microorganisms have been on the rise worldwide over the past few decades, and no new antibiotics have been introduced to the market in a considerable amount of time. Such situation highlights the urgency of discovering new antimicrobial drugs to address this pressing issue. Therefore, the objective of this study was to identify bioactive compounds against 15 species of bacteria and 5 species of fungi of clinical relevance through in vitro screening of 58 synthetic compounds from four chemical classes of our internal library of synthetic compounds. Our findings highlight arylpiperazines 18, 20, 26, 27, and 29, and the aminothiazole 50, as potent broad-spectrum antimicrobials (MICs = 12.5 - 15.6 mg.mL-1) against clinically relevant bacteria and fungi. Additionally, these compounds displayed low cytotoxicity against various host cells and a favorable in vitro pharmacokinetic profile for oral administration. Indeed, all six showed adequate lipophilicity, high gastrointestinal permeability, metabolic stability in human and mouse liver microsomes, and satisfactory aqueous solubility. Thus, they emerge as promising starting points for hit-to-lead studies towards new antibacterial and antifungal agents, especially against Staphylococcus epidermidis, Staphylococcus aureus, Lactobacillus paracasei and Candida orthopsilosis.

2.
Toxicon ; 238: 107569, 2024 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-38122835

RESUMEN

The present work addressed the abilities of two L-amino acid oxidases isolated from Bothrops moojeni (BmooLAAO-I) and Bothrops jararacussu (BjussuLAAO-II) snake venoms to control the growth and prevent the biofilm formation of clinically relevant bacterial pathogens. Upon S. aureus (ATCC BAA44) and S. aureus (clinical isolates), BmooLAAO-I (MIC = 0.12 and 0.24 µg/mL, respectively) and BjussuLAAO-II (MIC = 0.15 µg/mL) showed a potent bacteriostatic effect. Against E. coli (ATCC BAA198) and E. coli (clinical isolates), BmooLAAO-I (MIC = 15.6 and 62.5 µg/mL, respectively) and BjussuLAAO-II (MIC = 4.88 and 9.76 µg/mL, respectively) presented a lower extent effect. Also, BmooLAAO-I (MICB50 = 0.195 µg/mL) and BjussuLAAO-II (MICB50 = 0.39 µg/mL) inhibited the biofilm formation of S. aureus (clinical isolates) in 88% and 89%, respectively, and in 89% and 53% of E. coli (clinical isolates). Moreover, scanning electron microscopy confirmed that the toxins affected bacterial morphology by increasing the roughness of the cell surface and inhibited the biofilm formation. Furthermore, analysis of the tridimensional structures of the toxins showed that the surface-charge distribution presents a remarkable positive region close to the glycosylation motif, which is more pronounced in BmooLAAO-I than BjussuLAAO-II. This region may assist the interaction with bacterial and biofilm surfaces. Collectively, our findings propose that venom-derived antibiofilm agents are promising biotechnological tools which could provide novel strategies for biofilm-associated infections.


Asunto(s)
Bothrops , Venenos de Crotálidos , Serpientes Venenosas , Animales , Venenos de Crotálidos/toxicidad , L-Aminoácido Oxidasa/farmacología , L-Aminoácido Oxidasa/química , Staphylococcus aureus , Escherichia coli , Venenos de Serpiente/química , Bacterias , Biopelículas
3.
J Ethnopharmacol ; 319(Pt 3): 117315, 2024 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-37852339

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Maytenus ilicifolia Mart. ex Reissek, a medicinal plant used for treating gastritis, ulcers, and gastric disorders, possesses therapeutic properties attributed to diverse leaf compounds-terpenoids, alkaloids, flavonoids, phenols, and tannins, reflecting the ethnopharmacological knowledge of traditional users. AIMS OF THE STUDY: We aimed to assess the antioxidant and antiglycant capacities of Maytenus ilicifolia's ethanolic extract and organic fractions, identify bioactive compounds through HPLC-MS/MS analysis, and conduct phytochemical assessments. We also assessed their potential to inhibit digestive and cholinesterase enzymes, mitigate oxidation of human LDL and rat hepatic tissue, and examine their antimicrobial and cytotoxic properties. MATERIALS AND METHODS: Organic fractions (hexane - HF-Mi, dichloromethane - DMF-Mi, ethyl acetate - EAF-Mi, n-butanol - BF-Mi, and hydromethanolic - HMF-Mi) were obtained via liquid-liquid partitioning. Antioxidant (DPPH, FRAP, ORAC) and antiglycant (BSA/FRU, BSA/MGO, ARG/MGO/LDL/MGO models) capacities were tested. Phytochemical analysis employed HPLC-MS/MS. We also studied the inhibitory effects on α-amylase, acetylcholinesterase, butyrylcholinesterase, human LDL and rat hepatic tissue oxidation, antimicrobial activity, and cytotoxicity against RAW 264.7 macrophages. RESULTS: HPLC-ESI-MS/MS identified antioxidant compounds such as catechin, quercetin, and kaempferol derivatives. Ethanolic extract (EE-Mi) and organic fractions demonstrated robust antioxidant and antiglycant activity. EAF-Mi and BF-Mi inhibited α-amylase (2.42 µg/mL and 7.95 µg/mL) compared to acarbose (0.144 µg/mL). Most organic fractions exhibited ∼50% inhibition of acetylcholinesterase and butyrylcholinesterase, rivaling galantamine and rivastigmine. EAF-Mi, BF-Mi, and EE-Mi excelled in inhibiting lipid peroxidation. All fractions, except HMF-Mi, effectively countered LDL oxidation, evidenced by the area under the curve. These fractions protected LDL against lipid peroxidation. CONCLUSION: This study unveils Maytenus ilicifolia's ethanolic extract and organic fractions properties. Through rigorous analysis, we identify bioactive compounds and highlight their antioxidant, antiglycant, enzyme inhibition, and protective properties against oxidative damage. These findings underline its significance in modern pharmacology and its potential applications in healthcare.


Asunto(s)
Antiinfecciosos , Celastraceae , Maytenus , Humanos , Animales , Ratas , Peroxidación de Lípido , Acetilcolinesterasa , Butirilcolinesterasa , Antioxidantes/farmacología , Reacción de Maillard , Óxido de Magnesio , Espectrometría de Masas en Tándem , Fitoquímicos , alfa-Amilasas , Extractos Vegetales/farmacología
4.
Chem Biol Interact ; 384: 110716, 2023 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-37722575

RESUMEN

Congenital toxoplasmosis, caused by the opportunistic protozoan parasite T. gondii, can cause stillbirths, miscarriages and fetal abnormalities, as well as encephalitis and chorioretinitis in newborns. Available treatment options rely on antiparasitic drugs that have been linked to serious side effects, high toxicity and the development of drug-resistant parasites. The search for alternative therapeutics to treat this disease without acute toxicity for the mother and child is essential for the advancement of current therapeutic procedures. The present study aimed to unravel the mode of the anti-T. gondii action of Rottlerin, a natural polyphenol with multiple pharmacological properties described. Herein, we further assessed the antiparasitic activity of Rottlerin against T. gondii infection on the human trophoblastic cells (BeWo cells) and, for the first time, on human villous explants. We found that non-cytotoxic doses of Rottlerin impaired early and late steps of parasite infection with an irreversible manner in BeWo cells. Rottlerin caused parasite cell cycle arrest in G1 phase and compromised the ability of tachyzoites to infect new cells, thus highlighting the possible direct action on parasites. An additional and non-exclusive mechanism of action of Rottlerin involves the modulation of host cell components, by affecting lipid droplet formation, mitochondrial function and upregulation of the IL-6 and MIF levels in BeWo cells. Supporting our findings, Rottlerin also controlled T. gondii proliferation in villous explants with low toxicity and reduced the IL-10 levels, a cytokine associated with parasite susceptibility. Collectively, our results highlighted the potential use of Rottlerin as a promising tool to prevent and/or treat congenital toxoplasmosis.

5.
Future Sci OA ; 6(7): FSO587, 2020 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-32802394

RESUMEN

AIM: This paper reports on the antimycobacterial activity of the oleoresins and extracts obtained from Copaifera spp. MATERIALS & METHODS: The minimum inhibitory concentration (MIC) and fractional inhibitory concentration index techniques helped to evaluate the effect of these oleoresins and extracts against six strains of mycobacteria that cause tuberculosis. RESULTS & CONCLUSION: Among the assayed oleoresins and plant extracts, the Copaifera langsdorffii, Copaifera duckei, Copaifera reticulata and Copaifera trapezifolia oleoresins provided the lowest MIC values against some of the tested strains. The combination of Copaifera spp. samples with isoniazid did not evidence any synergistic action. Some Copaifera spp. oleoresins may represent a future source for the discovery of new antimycobacterial drugs due to their low MIC values.

6.
J Agric Food Chem ; 66(33): 8703-8713, 2018 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-30048138

RESUMEN

Solanum paniculatum L. is widely used in Brazilian folk medicine for the treatment of liver and gastrointestinal disorders as well as for culinary purposes and beverage production. Fractionation of hydroalcoholic [ethanol (EtOH) 70%] tincture from S. paniculatum leaves led to the isolation of six new spirostanic saponins which included 6- O-α-l-rhamnopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,23 R,25 S)-3ß,6α,23-trihydroxy-5α-spirostane (1), 6- O-ß-d-xylopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,23 R,25 R)-3ß,6α,23-trihydroxy-5α-spirostane (4), 3- O-α-l-rhamnopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,23 S,25 R)-3ß,6α,23-trihydroxy-5α-spirostane (5), 3- O-ß-d-xylopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,23 S,25 R)-3ß,6α,23-trihydroxy-5α-spirostane (6), 6- O-α-l-rhamnopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,25 S)-1ß,3ß,6α-trihydroxy-5α-spirostane (7), and 6- O-ß-d-xylopyranosyl-(1''→3')-ß-d-quinovopyranosyl-(22 S,25 S)-3ß,4ß,6α-trihydroxy-5α-spirostane (8) together with two known spirostanic saponins (2, 3). The structures of these compounds were determined by one-dimensional (1D) and two-dimensional (2D) NMR experiments in addition to high-resolution electrospray ionization mass spectrometry (HRESIMS) analyses. The 70% alcohol tincture, used as phytomedicine, exhibited promising activities against oral pathogens, including, Steptococcus sanguinis, St. oralis, St. mutans, St. mitis, and Lactobacillus casei with minimal inhibitory concentration (MIC) values ranging from 6.25 to 50 µg/mL. The saponin fraction, nonetheless, showed lower activity against all the strains tested (from 100 to >400 µg/mL).


Asunto(s)
Antibacterianos/química , Antibacterianos/farmacología , Enfermedades de la Boca/microbiología , Extractos Vegetales/química , Extractos Vegetales/farmacología , Solanum/química , Antibacterianos/aislamiento & purificación , Brasil , Humanos , Espectrometría de Masas , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta/química , Saponinas , Streptococcus/efectos de los fármacos , Streptococcus/crecimiento & desarrollo
7.
Chem Biodivers ; 11(3): 438-44, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24634073

RESUMEN

The chemical composition of the essential oil isolated from the aerial parts of Melampodium divaricatum (Rich.) DC. (Asteraceae) was characterized by GC-FID and GC/MS analyses. (E)-Caryophyllene (56.0%), germacrene D (12.7%), and bicyclogermacrene (9.2%) were identified as the major oil components. The antimicrobial activity of the oil against seven standard strains of oral pathogens from the American Type Culture Collection (ATCC) was evaluated by determining minimum inhibitory concentrations (MICs) using the microdilution method. MIC Values below 100 µg/ml were obtained against Streptococcus sobrinus (90 µg/ml), Lactobacillus casei (30 µg/ml), S. mutans (20 µg/ml), and S. mitis (18 µg/ml). In contrast, the MIC values of the major oil compound (E)-caryophyllene were higher than 400 µg/ml against all pathogens, suggesting that the activity of the oil might depend on minor oil components and/or on synergistic effects. The M. divaricatum essential oil is a promising agent to include in anticariogenic oral rinse formulations for the control of oral pathogens.


Asunto(s)
Antiinfecciosos/química , Asteraceae/química , Aceites Volátiles/química , Antiinfecciosos/aislamiento & purificación , Antiinfecciosos/farmacología , Asteraceae/metabolismo , Lacticaseibacillus casei/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Aceites Volátiles/aislamiento & purificación , Aceites Volátiles/farmacología , Componentes Aéreos de las Plantas/química , Componentes Aéreos de las Plantas/metabolismo , Streptococcus mitis/efectos de los fármacos , Streptococcus mutans/efectos de los fármacos , Streptococcus sobrinus/efectos de los fármacos
8.
Acta odontol. venez ; 52(1)2014. ilus, graf
Artículo en Español | LILACS | ID: lil-777820

RESUMEN

Este estudio evaluó la retención del S. mutans (ATCC 25175) en los cepillos dentales Oral B Complete® y Sensodyne Esmalte Care®, que poseen distintas características de fijación y anclaje de los filamentos en sus partes activas. Nueve cepillos dentales de cada marca comercial fueron esterilizados en autoclave y, a continuación, inoculados con S. mutans (ATCC 25175), previamente desarrollado en caldo Brain Heart Infusion (BHI). Los análisis de retención bacteriana se realizaron en los tempos de 04, 12 y 24 horas de incubación, a 37ºC y en microaerofilia, en triplicata. En esas etapas, los cepillos fueron lavados con agua esterilizada e introducidos en tubos Falcon con caldo BHI, del cual fueron preparadas diluciones decimales hasta 10-3 para las cuatro primeras horas, hasta 10-4 para 12 horas, y hasta 10-5 para 24 horas de incubación. Alícuotas de esas diluciones fueron sembradas en la superficie del Ágar BHI, siendo las placas incubadas en microaerofilia por 24h a 37ºC. Tras la incubación, fue realizado un recuento de las unidades formadoras de colonia por mL (UFC/mL) y el análisis estadístico (Tests de Tukey pareado, p?0,05). Fueron observadas diferencias estadísticamente significantes (p?0,05) entre lo tiempos de evaluación de 12 horas. Concluyese que el cepillo dental Oral B Complete® presentó, comparativamente a Sensodyne Esmalte Care®, mayor retención del S. mutans (ATCC 25175).


This work evaluated the retention of S. mutans ATCC 25175 in the Oral B Complete and Sensodyne Esmalte Care toothbrushes that have distinct characteristics of insertion and anchorage of the filaments in its active parts. Nine toothbrushes of each trademark were sterilized in autoclave and, following this procedure, inoculated with S. mutans ATCC 25175, previously developed in Brain Heart Infusion (BHI).The analyses of bacterial retention occurred in the times of 04, 12 and 24 hours after incubation, at 37ºC and in microaerophilic, in triplicate. In these stages, the toothbrushes were washed with sterilized water and enclosed in Falcon tubes with BHI broth, of which decimal dilutions up to 10-3 were made for the four first hours, up to 10-4 for 12 hours, and up to 10-5 for 24 hours of incubation. Aliquots of these dilutions were sown in the surface of agar BHI, and the Petri dishes were incubated in microaerophilic for 24 hours, in a temperature of 37ºC. After the incubation, the counting of the colony forming units and the statistical analysis (Tukey Test paired, p?0.05) were performed. Significant statistical differences were observed (p?0.05) between the times of evaluation of 12 hours. It was concluded that the Oral B Complete toothbrush presents, compared with Sensodyne Esmalte Care, greater retention of S. mutans ATCC 25175.


Asunto(s)
Humanos , Masculino , Femenino , Cepillado Dental/efectos adversos , Dispositivos para el Autocuidado Bucal , Streptococcus mutans/crecimiento & desarrollo , Streptococcus mutans/aislamiento & purificación , Placa Dental , Higiene Bucal
9.
Gerodontology ; 25(3): 187-94, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18194331

RESUMEN

OBJECTIVE: The purpose of this in vitro study was to evaluate the antimicrobial activity of acrylic resins containing different percentages of silver and zinc zeolite, and to assess whether the addition of zeolite alters the flexural and impact strength of the resins. BACKGROUND: The characteristics of acrylic resins support microorganism development that can threaten the health of the dentures user. MATERIAL AND METHODS: A microwave-polymerised (Onda-Cryl) and two heat-polymerised (QC20 and Lucitone 550) acrylic resins were used. The materials were handled according to the manufacturers' instructions. Fifty rectangular-shaped specimens (8 x 10 x 4mm) were fabricated from each resin and assigned to 5 groups (n = 10) according to their percentage of Irgaguard B5000 silver-zinc zeolite (0%- control, 2.5%, 5.0%, 7.5% and 10%). Flexural strength and Izod impact strength were evaluated. The antimicrobial activity against two strains of Candida albicans and two strains of Streptococcus mutans was assessed by agar diffusion method. Data were analysed statistically by one-way anova and Tukey's test at 5% significance level. RESULTS: The addition of 2.5% of Irgaguard B5000 to the materials resulted in antimicrobial activity against all strains. Flexural strength decreased significantly with the addition of 2.5% (QC20 and Lucitone 550) and 5.0% (Onda-Cryl) of Irgaguard B5000. The impact strength decreased significantly with the addition of 2.5% (Lucitone 550) and 5.0% (QC20 and Onda-Cryl) of zeolite. CONCLUSION: The addition of silver-zinc zeolite to acrylic resins yields antimicrobial activity, but may affect negatively the mechanical properties, depending on the percentage of zeolite.


Asunto(s)
Resinas Acrílicas/química , Antiinfecciosos Locales/farmacología , Zeolitas/farmacología , Análisis de Varianza , Antiinfecciosos Locales/química , Candida albicans/efectos de los fármacos , Análisis del Estrés Dental , Bases para Dentadura , Elasticidad , Ensayo de Materiales , Docilidad , Plata , Streptococcus mutans/efectos de los fármacos , Zeolitas/química , Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA